IBEX Limited (IBEX) Investment Analysis

1. Executive Summary

IBEX Limited (IBEX) represents a specialized tier in the global business process outsourcing (BPO) and customer experience (CX) technology sector, positioning itself as a leader in the transition from traditional labor-intensive models to "BPO 3.0," which prioritizes AI-first operations. The organization provides solutions that span the entire customer lifecycle, ranging from integrated digital marketing and customer acquisition to technical support and back-office services. These services are delivered through a proprietary Customer Lifecycle Experience (CLX) platform, which integrates three primary service suites: ibex Digital, ibex Connect, and ibex CX. Through this integrated architecture, the company manages approximately 170 million critical customer interactions annually for a diverse base of enterprise clients.

Revenue generation is fundamentally driven by service contracts with global brands, predominantly in the United States, which are fulfilled through a strategic global delivery network. As of the end of fiscal 2025 and the beginning of 2026, the company operates approximately 30 delivery facilities worldwide, employing over 33,000 personnel. A critical component of the company's revenue model is its shift toward high-margin offshore and nearshore delivery regions. Currently, 97% of the company’s workstations are located in high-growth, high-margin international geographies, including the Philippines, Jamaica, Pakistan, Nicaragua, and India.

The company’s revenue streams are segmented by industry vertical, with current performance highlighting a shift toward more complex, high-value sectors:

• Retail & E-commerce: This segment contributed significantly to recent growth, expanding by 25.0% year-over-year in the first quarter of fiscal 2026 and 17.2% in the second quarter.

• HealthTech: Emerging as the primary growth engine, this vertical expanded by 35.1% in the second quarter of fiscal 2026 and is on track to achieve an annual revenue run-rate of $100 million by the end of the fiscal year.

• Travel, Transportation, and Logistics: This segment grew by 20.2% in the most recent quarter, benefiting from increased demand for specialized logistics support.

• FinTech: After navigating regulatory and market volatility, this sector returned to growth in late 2025, supported by the acquisition of new enterprise clients.

• Technology and Telecommunications: These represent legacy sectors; while still significant, the company has intentionally managed its exposure to Telecommunications, which saw a decline of 23.1% recently as the business rotates toward higher-margin opportunities.

Customer concentration has historically been a point of scrutiny for the organization. At the time of its initial public offering (IPO), the company was heavily dependent on a few major accounts. However, management has executed a successful diversification strategy. The number of clients generating more than $5 million in annualized revenue has more than doubled, increasing from 13 at the IPO to 29 as of late 2025. Furthermore, the company now services 65 clients with more than $1 million in annualized revenue, compared to 32 at the time of its IPO. While the top three clients still account for 26% of total revenue, the largest single client now represents only 10% of total billings, reflecting a significantly more balanced risk profile.

Financial results for the first half of fiscal 2026 indicate record-level performance, with revenue reaching $315.4 million for the six-month period, a 16.6% increase over the prior year. This growth is being converted efficiently into profitability, with net income rising 44.4% to $24.3 million during the same period. The company maintains a robust balance sheet with total debt of only $1.4 million and substantial available credit, positioning it to continue its strategic investments in artificial intelligence and geographic expansion into markets like India.

2. Business Drivers & Strategic Overview

The strategic evolution of IBEX is predicated on three primary pillars: the pivot to high-margin offshore delivery, the aggressive deployment of AI-powered solutions, and a robust "new logo engine" that targets high-growth industry verticals. This strategy is designed to decouple revenue growth from headcount expansion, thereby increasing operating leverage and long-term margin potential.

Revenue Drivers and Vertical Expansion

The primary driver of revenue growth is the company’s "new logo engine," which has been highly successful in securing contracts within the HealthTech and FinTech sectors. In HealthTech specifically, the company has leveraged its India operations to provide specialized services such as revenue cycle management and credentialing, moving beyond simple customer support into more mission-critical business processes. This transition into higher-complexity work allows for higher pricing power and greater client retention.

Vertical-specific growth rates highlight the efficacy of this strategy. In the second quarter of fiscal 2026, HealthTech grew 35.1%, Travel, Transportation and Logistics grew 20.2%, and Retail & E-commerce grew 17.2%. These gains more than offset the strategic reduction in lower-margin Telecommunications revenue. The company's digital and omnichannel services now account for 82% of total revenue, which is a critical metric for assessing the durability of the business in a digital-first economy.

Strategic Geographic Footprint

IBEX has methodically shifted its delivery footprint to offshore and nearshore regions to optimize margins. With 97% of its workstations now in these regions, the company can offer highly competitive pricing while expanding its own profitability. The expansion into India, initiated in March 2025, is a centerpiece of this strategy. Within less than a year, the company established two production sites in India with nearly 1,000 agents, providing a scalable, low-cost talent pool for global enterprise clients.

In the United States, the company has transitioned to a high-utilization work-at-home model, achieving over 100% capacity utilization while reducing the overhead costs associated with physical facilities. This "onshore-to-offshore" mix shift is a major driver of the 80 basis point improvement in adjusted EBITDA margins observed in recent quarters.

Competitive Advantages and AI Differentiation

The company’s competitive advantage is rooted in its proprietary technology suite and a culture that emphasizes high employee engagement. The ibex Wave iX suite includes a range of AI-powered solutions:

• Agentic AI: Developing solutions that handle end-to-end customer journeys autonomously, particularly for repetitive or low-complexity inquiries.

• Internal Productivity Tools: Purpose-built AI is used internally to accelerate agent hiring and training—a process termed "speed to green"—which minimizes the non-billable training period and improves gross margins.

• Advanced Analytics: Technologies such as AdCast AI, RefleCX, and Witness provide clients with deep insights into customer sentiment and behavior, allowing IBEX to act as a strategic consultant rather than just a service provider.

Furthermore, IBEX’s operational excellence is reflected in its industry-leading culture. The company reported an employee Net Promoter Score (eNPS) of 78, which management describes as "Best in Class". This high engagement is a critical defensive moat, as it leads to lower attrition rates and higher quality of service, directly influencing client satisfaction and contract renewals.

3. Financial Performance & Valuation

IBEX’s financial performance through fiscal 2025 and the first half of 2026 has been characterized by consistent outperformance against both management guidance and analyst expectations. The company is currently operating with record levels of revenue and profitability.

Recent Historical Performance and 2025 Metrics

In fiscal year 2025, IBEX achieved revenue of $558.8 million, representing a 10% increase year-over-year. This performance laid the groundwork for an acceleration into fiscal 2026. For the second quarter of fiscal 2026 (ended December 31, 2025), IBEX reported revenue of $164.2 million, a 16.7% increase compared to the prior year quarter. This result exceeded analyst estimates by approximately $7.2 million.

For the full calendar year 2025, the company surpassed $600 million in revenue and generated $80 million in adjusted EBITDA with a 13% margin. This growth has been driven primarily by high-margin offshore revenue, which grew 16.2% year-over-year in the most recent quarter.

Balance Sheet, Cash Flow, and Capital Management

The company maintains an exceptionally strong balance sheet with net cash of approximately $14.0 million as of December 31, 2025. Total debt remains negligible at $1.4 million. Cash flow from operations for the first half of fiscal 2026 reached $22.3 million, more than double the $8.9 million generated in the same period a year earlier.

Management has utilized this cash flow for both reinvestment and shareholder returns. Capital expenditures were increased to $11.7 million in the most recent quarter (7.1% of revenue) to meet surging demand in offshore regions, particularly in India. Simultaneously, the company remained active in its share repurchase program, buying back 170,000 shares for $5.6 million during the first half of the fiscal year. The weighted average shares outstanding have decreased from 16.5 million to 14.7 million, contributing significantly to the 45% growth in diluted EPS.

Current Valuation Multiples

Despite record financial results, IBEX continues to trade at valuation multiples that appear low relative to its historical averages and peer group. Based on a current share price of approximately $31.13 and a trailing twelve-month (TTM) EPS of $3.04, the P/E ratio is approximately 10.2x.

The company's enterprise value relative to EBITDA (EV/EBITDA) is estimated at approximately 5.5x to 6.5x, reflecting a significant discount to larger peers such as Concentrix or TaskUs, particularly when considering IBEX's superior organic growth rates of 16-17% compared to the more modest growth of legacy providers.

4. Risk Assessment & Macroeconomic Considerations

While IBEX is currently executing at a high level, the company faces several structural and macroeconomic risks that could impede its 5-year growth trajectory. These risks range from client-specific dependencies to broad technological shifts.

Client Concentration and Contract Durability

Although IBEX has successfully diversified its client base, the top three clients still represent 26% of total revenue. The loss of any of these major accounts, or a significant reduction in their volume, would have a disproportionate impact on profitability given the fixed costs associated with delivery centers. Furthermore, there is an emerging risk of "insourcing," where enterprise clients may choose to bring customer service operations back in-house to gain more direct control over their AI deployments.

Artificial Intelligence: Disruption vs. Opportunity

The rapid advancement of generative AI is a fundamental risk. While management views AI as a tool to enhance agent productivity and win "new logo" business, there is a risk that AI agents could automate such a high volume of interactions that the total demand for human agents—the basis of "seat-based" revenue—decreases significantly. If the industry shifts toward purely outcome-based models before IBEX can fully monetize its proprietary AI stack, margins could be pressured as clients demand the productivity gains for themselves.

Macroeconomic and Geopolitical Factors

As a global operator, IBEX is highly exposed to macroeconomic and geopolitical volatility:

• Currency Fluctuations: A significant portion of the company’s operating expenses are in local currencies (e.g., Philippine Peso, Jamaican Dollar, Indian Rupee), while revenue is in U.S. Dollars. Significant devaluations of the U.S. Dollar or inflation in labor costs in these regions could compress margins.

• Geopolitical Instability: Operations in countries like the Philippines and Pakistan are subject to political unrest and changes in regulatory environments. Natural disasters, such as typhoons or hurricanes in the Caribbean and Southeast Asia, also present recurring risks to operational continuity.

• Taxation: The company currently benefits from tax holidays in several jurisdictions. Any changes to international tax laws, such as the implementation of global minimum taxes or the expiration of local holidays, could increase the effective tax rate from its current 20-22% level.

Labor and Competitive Pressures

The BPO industry remains highly competitive and labor-intensive. IBEX must compete with much larger organizations—Concentrix, Teleperformance, and TaskUs—for both clients and talent. Rising wages in key offshore hubs could erode the company's cost advantage if it is unable to pass those costs through to clients via contractual adjustments. Additionally, any reputational harm stemming from data security incidents, such as those faced by peers recently, could lead to rapid client churn.

5. 5-Year Scenario Analysis

The following 5-year projections for IBEX Limited are based on current fundamentals and strategic initiatives. The current share price of $31.13 serves as the baseline for evaluating total return potential.

Base Case: Continued Offshore Dominance and AI Synergy

In the base case, IBEX continues to execute its "BPO 3.0" strategy, successfully integrating AI into its workflows to maintain a competitive edge. Revenue growth is driven by the scaling of the HealthTech and FinTech verticals, while the India expansion reaches its full planned capacity. The company manages to offset legacy Telecommunications declines with new logo acquisitions.

• Key Fundamentals: Revenue CAGR of 10%; Adjusted EBITDA margins expanding to 14.5% as offshore mix increases to 60%; tax rate remains stable at 21%; share count is reduced by 3% annually through consistent buybacks.

• Assumptions: Terminal Non-GAAP P/E multiple of 12x (moving toward the industry average).

• 5-Year Outcome: Projected revenue of ~$920M and Adjusted EPS of ~$5.85.

• Projected Share Price (5 Years): $70.20.

High Case: Vertical Leadership and Outcome-Based Pricing Breakout

The high case assumes IBEX becomes the dominant player in the mid-market enterprise CX space. The HealthTech vertical grows at 30%+ CAGR, becoming a $250M+ segment. The company successfully transitions a large portion of its revenue to "outcome-based" models enabled by its Agentic AI, significantly decoupling profitability from headcount.

• Key Fundamentals: Revenue CAGR of 15%; Adjusted EBITDA margins expanding to 17% due to outcome-based pricing; share count reduced by 5% annually; India becomes the primary profit engine.

• Assumptions: Terminal Non-GAAP P/E multiple of 16x, reflecting a re-rating to a "tech-enabled services" valuation.

• 5-Year Outcome: Projected revenue of ~$1.25B and Adjusted EPS of ~$9.50.

• Projected Share Price (5 Years): $152.00.

Low Case: Macro Contraction and AI Cannibalization

The low case assumes a severe global recession that forces enterprise clients to slash CX budgets. Simultaneously, AI agents automate interactions faster than IBEX can replace the volume with new logos, leading to a contraction in seat-based revenue. Pricing pressure from larger competitors leads to margin compression.

• Key Fundamentals: Revenue CAGR of 2%; Adjusted EBITDA margins contract to 10%; share repurchases are suspended to preserve cash; tax rate increases to 25% due to regulatory changes.

• Assumptions: Terminal Non-GAAP P/E multiple of 8x (reflecting a "value trap" scenario).

• 5-Year Outcome: Projected revenue of ~$680M and Adjusted EPS stagnant at ~$3.10.

• Projected Share Price (5 Years): $24.80.

Probability Weighted Outcome

The probability-weighted target of $79.53 suggests that even with a conservative low-case weighting, the fundamental growth of the business justifies a share price significantly higher than current market levels.

DYNAMISM DRIVING VALUE

6. Qualitative Scorecard

Management Alignment: 8/10

CEO Bob Dechant holds approximately 1.35% of the company’s shares directly, representing a substantial personal investment of over $5.4 million. Compensation for the executive team is heavily weighted toward performance-based bonuses and equity awards tied to critical revenue and EBITDA targets. While there has been minor insider selling for tax-related purposes, the overall trend reflects a management team with significant "skin in the game" and a focus on long-term shareholder value.

Revenue Quality: 9/10

IBEX has successfully shifted its revenue mix away from low-value, commodity telecom support toward high-value, digitally-enabled interactions. Currently, 82% of total revenue is derived from digital and omnichannel services. The rapid ascent of the HealthTech vertical provides a recurring, mission-critical revenue stream that is less sensitive to economic cycles than retail or consumer tech.

Market Position: 8/10

IBEX is clearly winning market share, as evidenced by four consecutive quarters of double-digit organic growth (16-17%) at a time when larger industry peers are reporting much lower or even negative organic growth. The company is effectively positioning itself as a "market disruptor" through its agile AI adoption and focus on mid-to-large enterprise clients who feel neglected by the mega-BPOs.

Growth Outlook: 9/10

The outlook is bolstered by the "new logo engine" and the successful entry into the Indian market, which provides a high-talent, low-cost delivery option that enterprise clients increasingly demand. The clear path to $100M+ in HealthTech revenue by the end of fiscal 2026 serves as a tangible near-term growth catalyst.

Financial Health: 10/10

With a debt-to-equity ratio of nearly zero and total debt of only $1.4 million against record quarterly cash flows, IBEX’s financial health is impeccable. The company’s ability to fund its own expansion in India while simultaneously repurchasing shares and maintaining a net cash position of $14.0 million is a testament to its disciplined financial management.

Business Viability: 7/10

The durability of the business is strong, but it faces an industry-wide "choke point" regarding the speed of AI automation. The ultimate viability of the business depends on management’s ability to monetize its Wave iX platform and transition to outcome-based pricing before AI agents cannibalize too much of the traditional seat-based revenue.

Capital Allocation: 9/10

Management has demonstrated high competence in capital allocation. They have prioritized high-ROI investments in offshore facilities and AI technology while returning over $5.6 million to shareholders via buybacks in the first half of fiscal 2026. The reduction in share count has been a major driver of the superior EPS growth relative to net income growth.

Analyst Sentiment: 6/10

Consensus sentiment remains neutral, with a "Hold" rating and an average price target of $35.00. Analysts appear to be waiting for more evidence that AI will be a long-term tailwind rather than a headwind for the BPO sector as a whole, despite IBEX's specific outperformance.

Profitability: 8/10

Adjusted EBITDA margins of 12.6% are strong and expanding, supported by the ongoing shift to offshore delivery. The company's net margin of 7.4% is healthy for the services industry and shows a positive trajectory.

Track Record: 8/10

Since its 2020 IPO, IBEX has a consistent history of meeting or exceeding its financial guidance and delivering record results. The company has successfully navigated the post-pandemic labor market and the rise of generative AI, demonstrating organizational resilience and adaptability.

Overall Blended Score: 8.2 / 10

SUPERIOR OPERATIONAL EXECUTION

7. Conclusion & Investment Thesis

IBEX Limited is currently a mispriced asset in a sector undergoing a major technological transformation. The company has demonstrated a superior ability to acquire "new logo" business in high-margin verticals like HealthTech and Retail, resulting in organic growth rates that are among the highest in the BPO industry. The strategic expansion into India and the successful deployment of the Wave iX AI suite have created a foundation for continued margin expansion and competitive differentiation.

The core investment thesis is centered on three primary factors:

1. Multiple Expansion: As IBEX continues to prove that AI is a tailwind for its business model, the current depressed valuation (10.2x P/E) should gravitate toward industry averages, providing a significant uplift to the share price.

2. Vertical Dominance: The HealthTech vertical is on a path to becoming a major revenue contributor, which should lead to higher quality, more recurring earnings and a potential valuation re-rating.

3. Aggressive Capital Return: The ongoing share repurchase program, fueled by strong operating cash flows and a debt-free balance sheet, will continue to amplify EPS growth for remaining shareholders.

While risks related to AI-driven automation and client concentration are real, they are largely mitigated by the company's technical agility and its focus on complex, omnichannel interactions that still require human-in-the-loop oversight. IBEX appears to be an undervalued growth story that is being overlooked by the market due to broader sector-level concerns.

UNDERVALUED DISRUPTIVE LEADER

8. Technical Analysis, Price Action & Short-Term Outlook

IBEX's technical profile is currently bearish to neutral, with the stock trading at approximately $31.13, which is 12.1% below its 200-day simple moving average of $35.42. Recent price action has been negatively impacted by minor insider selling and a broader market rotation away from mid-cap service providers, despite the company's record earnings beat on February 5, 2026. The short-term outlook remains cautious until the stock can regain its 50-day and 200-day moving averages, though the current oversold conditions and strong fundamental guidance of $620-$630M in revenue suggest a potential for a technical rebound in the coming weeks.

OVERSOLD FUNDAMENTAL OPPORTUNITY